Trial NCT03735290

View at ClinicalTrials.gov 
Org. Study IDs: IM-202

Last trial update was posted on 2022-03-16

MeSH Interventions

Pembrolizumab

MeSH Conditions

Adenocarcinoma Carcinoma, Squamous Cell Squamous Cell Carcinoma of Head and Neck

Other Conditions

Carcinoma, Squamous Cell of Head and Neck Gastric Adenocarcinoma Gastroesophageal Junction Adenocarcinoma Non-small Cell Lung Cancer

Stopping Reasons

Decision made not to move to Phase 2

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID